Chemical Papers
pressure tube, bromobutane (1.180 ml, 11 mmol) was added
slowly with continuous stirring at 25 °C. Mixture was stirred
for 16 h at 50 °C in nitrogen atmosphere. The solution was
washed with dry diethyl ether and remaining residue evapo-
rated on a rotavapour. MBPIP.Br was treated with sodium
acetate in similar fashion as described compound 2. A solid
precipitate of NaCl was removed by fltration. White liquid
product was kept under high vaccum at 50 °C for 3 h (yield;
95%). The product N-butyl-N-methylpiperidinium acetate
(100 MHz, CDCl3): δ 170.4, 140.5, 128.3, 127.8, 126.5,
29.7, 29.2, 21.2, 19.1, 9.8.
Acetic acid 2,5-dioxo-cyclopentyl ester (entry 6) FTIR
(ATR, νcm−1): 2986, 2371, 1714, 1374, 1163, 1051, 824,
1
644, 507; H NMR (400 MHz, CDCl3): δ = 2.83 (s, 4H),
2.34 (s, 3H); 13C NMR (100 MHz, CDCl3): 169.0, 165.6,
29.7, 25.6, 17.6.
Acetic acid 2-oxo-1,2-diphenyl-ethyl ester (entry 7) FTIR
(ATR, νcm−1): 3062, 2360, 1693, 1597, 1448, 1372, 1225,
1
1
(4) was confirmed by H NMR (400 MHz, DMSO-d6):
1055, 971, 862, 755, 695, 582, 526; H NMR (400 MHz,
δ=3.39–3.32 (m, 6H), 3.09 (s, 3H), 2.05 (s, 3H), 1.78 (s,
br, 3H), 1.67–1.45 (m, 4H), 1.33–1.24 (m, 2H), 0.91 (t, 3H.
J=7.2 Hz). FTIR (ATR, νcm−1): 2959, 2874, 1474, 1353,
1225, 1050, 940, 673, 576, cm−1.
CDCl3): δ 7.47 (d, J = 4.0 Hz, 2H), 7.45–7.40 (m, 2H),
7.39–7.33 (m, 4H), 6.86 (s, 1H), 2.20 (s, 3H); 13C NMR
(100 MHz, CDCl3): 193.8, 170.5, 134.7, 133.6, 128.9, 77.7,
29.5, 21.7, 14.2.
General procedure for Acetylation of alcohols To mix-
ture of an alcohols (10.0 mmol), acetic anhydride (Ac2O)
(15 mmol; 1.5 equivalent) and 10 mol % of catalyst [Boc-
NHCH2CH2MIM] [OAc] was stirred at room temperature.
Completion of reactions was monitored through TLC. After
completion of the reactions, the reaction mixture evaporated
under vacuum till dryness. The residue was extracted with
diethyl ether and concentrated. The crude products were
purifed by column chromatography on neutral alumina
using hexanes/ethyl acetate as the eluent to give correspond-
ing products. Acetic acid 4-methoxy-benzyl ester (entry 1)
FTIR (ATR, νcm−1): 2956, 2838, 2360, 1733, 1612, 1515,
Acetic acid 2-acetoxymethyl-ethyl ester (entry 8) FTIR
(ATR, νcm−1): 2963, 2289, 1738, 1371, 1212, 1045, 957,
1
847; H NMR (400 MHz, CDCl3): δ 5.27–5.22 (m, 2H),
4.31–4.27 (m, 1H), 4.18–4.13 (m, 1H), 2.09 (s, 9H);
13CNMR (100 MHz, CDCl3): 170.2, 69.0, 62.2, 29.6, 20.7.
Acetic acid octyl ester (entry 9) FTIR (ATR, νcm−1):
2926, 2860, 1739, 1462, 1369, 1234, 1038, 960, 724, 640;
1H NMR (400 MHz, CDCl3): δ 4.05 (t, J = 6.8 Hz, 2H),
2.04 (s, 3H), 1.65–1.60 (m, 2H), 1.58–1.27 (m, 10H), 0.90
(t, J=6.8, Hz, m, 3H); 13C NMR (100 MHz, CDCl3): 171.2,
64.6, 31.9, 31.7, 29.7, 29.3, 29.2, 29.1, 28.6, 25.9, 22.6,
21.0, 14.0.
1
1221, 1024, 958, 813, 756, 607, 561, 518, 431, 408; H
Acetic acid cyclohexyl ester (entry 10) 1H NMR
(400 MHz, CDCl3): δ 4.76–4.70 (m, 1H), 2.02 (s, 3H),
1.86–180 (m, 4H), 174–1.70 (m, 6H), 1.57–1.44 (m, 2H);
13C NMR (100 MHz, CDCl3): 170.6, 72.7, 35.5, 31.6, 29.7,
25.4, 23.8, 22.6, 21.4.
NMR (400 MHz, CDCl3): δ=7.30–7.25 (m, 2H), 6.90–6.87
(m, 2H), 5.04 (s, 2H), 2.09 (s, 3H); 13C NMR (100 MHz,
CDCl3): δ 170.9, 159.6, 130.1, 128.1, 113.9, 113.8, 66.1,
55.3, 29.7, 21.0
Acetic acid 4-fuoro-benzyl ester (entry 2) FTIR (ATR,
Acetic acid 2-(9H-fuoren-9-ylmethoxycarbonylamino)-
ethyl ester (entry 11) FTIR (ATR, νcm−1): 3319, 2930,
2364, 1720, 1550, 1441, 1258, 1157, 1055, 956, 613, 471;
1H NMR (400 MHz, CDCl3): 7.77–7.26 (m, 8H); 4.474.42
(m, 3H), 4.23–4.00 (m, 2H), 3.78–3.32 (m, 2H), 2.07 (s,
3H); 13C NMR (100 MHz, CDCl3): δ 177.0, 143.8, 141.4,
127.7, 127.1, 125.0, 120.1, 47.4, 40.2, 20.9.
νcm−1): 2360, 1737, 1605, 1511, 1379, 1221, 1158,
1
1027, 822, 766, 607, 551; H NMR (400 MHz, CDCl3):
δ=7.32–7.07 (m, 2H), 7.06–7.02 (m, 2H), 5.06 (s, 2H), 2.09
(s, 3H); 13C NMR (100 MHz, CDCl3): δ 170.8, 163.9, 161.4,
131.8, 130.3, 130.2, 115.6, 115.3, 65.5,20.9.
Acetic acid 4-chloro-benzyl ester (entry 3) FTIR (ATR,
νcm−1): 2359, 1735, 1599, 1493, 1377, 1222, 1092, 1014,
803, 530; 1H NMR (400 MHz, CDCl3): δ=7.34–7.32 (m,
2H), 7.29–7.25 (m, 2H), 5.06 (s, 2H), 2.09 (s, 3H); 13C NMR
(100 MHz, CDCl3): δ 170.7, 134.4, 134.1, 129.6, 128.7,
65.4, 29.7, 20.9.
3α-12α-Diacetoxy-5β-cholan-24-oic Acid methyl ester
(12) 1H NMR (400 MHz, CDCl3): 5.07 (d, 1H, J=2.8 Hz),
4.70 (m, 1H), 3.66 (s, 3H), 2.34–2.31 (m, 1H), 2.22–2.20
(m, 1H),2.10 (s, 3H), 2.03 (s, 3H), 1.88–1.10 (m, 24H), 0.90
(s, 3H), 0.81 (s, 3H), 0.79 (s, 3H): 13C NMR (100 MHz,
CDCl3): 174.6, 170.5, 170.4, 75.9, 74.2, 51.5, 49.4, 47.6,
45.0, 41.8, 35.7, 34.7, 3.4.4, 34.0, 32.2, 31.0, 30.8, 27.3,
26.9, 26.6, 25.8, 25.6, 23.4, 23.0, 21.4, 21.3, 17.5.
3α-Acetoxy-5β-cholan-24-oic acid methyl ester (13)
1H NMR (400 MHz, CDCl3): 4.71 (d, 1H, J = 4.8 Hz),
2.40–2.36 (m, 1H), 2.30–2.26 (m, 1H), 2.17 (s, 3H), 2.02 (s,
3H), 1.98–0.90 (m, 32H), 0.64 (s, 3H): 13C NMR (100 MHz,
CDCl3): 178.0, 76.7, 74.4, 56.5, 56.0, 42.7, 41.9, 40.4, 40.1,
35.8, 35.3, 35.0, 34.6, 32.2, 30.8, 30.6, 28.1, 27.0, 26.6,
26.3, 24.2, 23.3, 21.4, 20.8, 18.2.
Acetic acid benzhydryl ester (entry 4) FTIR (ATR,
νcm−1): 3033, 2360, 1737, 1495, 1370, 1227, 1020, 743,
697, 549; 1H NMR (400 MHz, CDCl3): δ=7.34–7.25 (m,
10H), 6.82 (s, 2H), 2.15 (s, 3H); 13C NMR (100 MHz,
CDCl3) 170.0, 140.2, 127.8, 77.3, 30.0, 22.0, 14.1
Acetic acid 1-phenyl-propyl ester (entry 5) FTIR (ATR,
νcm−1): 3385, 3152, 2975, 2365, 1701, 1518, 1370, 1247,
1
1164, 1011, 849, 755; H NMR (400 MHz, CDCl3):
δ = 7.34–7.30 (m, 2H), 7.39–7.25 (m, 2H), 5.66 (t, 1H),
2.08 (s, 3H), 1.97–1.77 (q, 2H), 0.87 (t, 3H); 13C NMR
1 3